KNKamrun Nahar

Kamrun Nahar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamrun Nahar has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Antidiabetic and Antioxidant Potential of Methanolic Extract of Bixa orellana Seeds

    by Tamanna Sharmin Tonny, Arghya Prosun Sarkar, Kamrun Nahar, Sumaira Jahan, Ivana Afroze, Bidduth Kumar Sarkar, Matrika Saha Roy

    Diabetes is considered a serious health problem in Bangladesh and worldwide. The disease is infesting all over the mother earth possessing the most damage associated with physical, mental and financial situation of the population. In this context, it’s truly essential to find an effective, safe yet economically suitable alternative medicine compared to commercially available noxious chemical drugs. Objective: This study aims to find the potential of an alternative natural extract produced from Bixa orellana seeds which is safer and more affordable comparable to the commercially available synthetic agents to reduce Hyperglycemia. It also makes effort to find the seed extracts’ ability to reduce oxidation in comparison to a standard drug, Ascorbic acid. Methodology: This is a Pharmacological study using animal model utilising rat as subjects. The rats were induced as diabetic by injecting alloxan intraperitonially and as treatment Bixa Orellana seed extracts were given to them at 500mg/kg and 1000mg/kg doses and compared with the hypogycemic effect of standard anti-diabetic drug, Metformin Hydrochloride at the dose of 100mg/kg. For analyzing the anti-oxidant activity, the DPPH free radical scavenging assay method has been used, where the IC50 values of both the Bixa Orellana seed extract and the reference drug, Ascorbic acid was collated. Results: It was found that the seed extracts used at 500 mg/kg and 1000 mg/kg evidently reduced the blood glucose level as opposed to the diabetic control group, more importantly with the rats treated with standard, Metformin Hydrochloride. Therefore, the study revealed that the seed extract can be effectively used to treat diabetic patients without any side effects. This experimentation, also by assessing the IC50 values, disclosed that the Bixa Orellana seed extract has moderate to substantial anti-oxidant potential in contrary to the reference drug.


  • Open Access

    Association between Pre-Eclampsia and Spontaneous Prelabour Rupture of Membrane (Prom) in Pregnancy

    by Suraiya Apsara, Umme Sayeeda Bilkish, K M Reaz Morshed, Kamrun Nahar, Luna Farhana Hoque, Nafeesa Binti Hussain

    Background: Pre-eclampsia and other hypertensive disorder in pregnancy are among the top causes of maternal and perinatal death globally. About 10% of all pregnancies have pre labor (premature) rupture of membranes (PROM), of which 7%–8% occur after 37–42 weeks. The objective of the study was to observe if pre-eclampsia is associated with spontaneous PROM. Method: Eighty (80) eligible pregnant women with gestational age ≥20 weeks were included in this study. They were divided into 2 equal case and control groups; 40 pregnant women with Pre-eclampsia and 40 pregnant women with normal blood pressure. The association of the risk of spontaneous PROM was assessed among these groups. Results: In this study 87.5% of the Pre-eclampsia case group and 75% of the normotensive control group were primigravida. There was a significant association between the gestational age of 82.5% of the Pre-eclampsia group and 70% of the normotensive group being full term (p=0.034). In the Pre-eclampsia group, there were 29(72.5%) PROM with a significant association (p=0.010), whereas in the normotensive group, there were 4 (10%) PROM with no significant association. The risk of PROM was found among Pre-eclampsia patients. Conclusion: In this study, we concluded that Pre-eclampsia is associated with the risk of spontaneous PROM.